Expression in BHK Cells of Two Human TNF Receptors and Their Interaction with hTNF-alpha.
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai).
1999;31(1):25-30. PubMed PMID:
12142910.
Overexpressed Human TNF Receptor-75 Can Independently Mediate hTNFalpha-induced Cytotoxicity in BHK-21 Cells.
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai).
1999;31(6):637-642. PubMed PMID:
12110927.
[Computer modeling and experimental research of interactions between two anti-hTNF alpha monoclonal antibody variable regions and hTNF alpha].
Sheng Wu Gong Cheng Xue Bao.
2000 Jan;16(1):36-41. PubMed PMID:
10883273.
TNF receptor-associated factor-2 binding site is involved in TNFR75-dependent enhancement of TNFR55-induced cell death.
Cell Res.
2001 Sep;11(3):217-22. doi: 10.1038/sj.cr.7290089. PubMed PMID:
11642407.
Dual function of human necrosis factor receptor 75 in cytotoxicity induced by human tumor necrosis factor alpha.
Acta Pharmacol Sin.
2001 Nov;22(11):1039-44. PubMed PMID:
11749798.
Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase.
Curr Biol.
2002 Jul 9;12(13):1086-99. doi: 10.1016/s0960-9822(02)00924-7. PubMed PMID:
12121615.
Studies on interaction between hTNF-alpha and its two receptors with expressed hsTR55-preS1/hsTR75-preS1 fusion soluble receptors.
J Immunol Methods.
2003 Mar 1;274(1-2):199-207. doi: 10.1016/s0022-1759(02)00520-3. PubMed PMID:
12609545.
Role of histone H3 lysine 27 methylation in X inactivation.
Science.
2003 Apr 4;300(5616):131-5. doi: 10.1126/science.1084274. Epub 2003 Mar 20. PubMed PMID:
12649488.
Purification of histone methyltransferases from HeLa cells.
Methods Enzymol.
2004;377:213-26. doi: 10.1016/S0076-6879(03)77012-8. PubMed PMID:
14979027.
Ring1b-mediated H2A ubiquitination associates with inactive X chromosomes and is involved in initiation of X inactivation.
J Biol Chem.
2004 Dec 17;279(51):52812-5. doi: 10.1074/jbc.C400493200. Epub 2004 Oct 26. PubMed PMID:
15509584.
Developmental regulation of Suz 12 localization.
Chromosoma.
2005 Aug;114(3):183-92. doi: 10.1007/s00412-005-0008-6. Epub 2005 Jun 29. PubMed PMID:
15986205.
G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis.
Nat Cell Biol.
2006 Feb;8(2):188-94. doi: 10.1038/ncb1353. Epub 2006 Jan 15. PubMed PMID:
16415856.
Histone demethylation by a family of JmjC domain-containing proteins.
Nature.
2006 Feb 16;439(7078):811-6. doi: 10.1038/nature04433. Epub 2005 Dec 18. PubMed PMID:
16362057.
Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A.
Science.
2006 May 5;312(5774):748-51. doi: 10.1126/science.1125162. Epub 2006 Apr 6. PubMed PMID:
16601153.
PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation.
Mol Cell.
2007 Mar 23;25(6):801-12. doi: 10.1016/j.molcel.2007.03.001. Epub 2007 Mar 15. PubMed PMID:
17363312.
The Saccharomyces cerevisiae histone demethylase Jhd1 fine-tunes the distribution of H3K36me2.
Mol Cell Biol.
2007 Jul;27(13):5055-65. doi: 10.1128/MCB.00127-07. Epub 2007 Apr 30. PubMed PMID:
17470555; PubMed Central PMCID:
PMC1951470.
In vitro histone demethylase assays.
Methods Mol Biol.
2009;523:249-61. doi: 10.1007/978-1-59745-190-1_17. PubMed PMID:
19381934.
Inhibition of SUV39H1 methyltransferase activity by DBC1.
J Biol Chem.
2009 Apr 17;284(16):10361-6. doi: 10.1074/jbc.M900956200. Epub 2009 Feb 13. PubMed PMID:
19218236; PubMed Central PMCID:
PMC2667723.
Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion.
EMBO J.
2010 Nov 3;29(21):3673-87. doi: 10.1038/emboj.2010.239. Epub 2010 Sep 24. PubMed PMID:
20871592; PubMed Central PMCID:
PMC2982762.
Writer meets eraser in HOTAIR.
Acta Biochim Biophys Sin (Shanghai).
2011 Jan;43(1):1-3. doi: 10.1093/abbs/gmq110. Epub 2010 Dec 6. PubMed PMID:
21138898.
MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9a.
Nat Commun.
2011 Nov 15;2:533. doi: 10.1038/ncomms1549. PubMed PMID:
22086334; PubMed Central PMCID:
PMC3286832.
p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression.
Oncogene.
2014 Feb 6;33(6):734-44. doi: 10.1038/onc.2013.6. Epub 2013 Feb 4. PubMed PMID:
23376847; PubMed Central PMCID:
PMC3912226.
In vitro histone demethylase assays.
Methods Mol Biol.
2015;1288:109-22. doi: 10.1007/978-1-4939-2474-5_8. PubMed PMID:
25827878.
MPP8 and SIRT1 crosstalk in E-cadherin gene silencing and epithelial-mesenchymal transition.
EMBO Rep.
2015 Jun;16(6):689-99. doi: 10.15252/embr.201439792. Epub 2015 Apr 13. PubMed PMID:
25870236; PubMed Central PMCID:
PMC4467853.
Histone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2.
J Biol Chem.
2015 Sep 11;290(37):22795-804. doi: 10.1074/jbc.M114.612945. Epub 2015 Jul 28. PubMed PMID:
26221039; PubMed Central PMCID:
PMC4566250.
E3-Independent Constitutive Monoubiquitination Complements Histone Methyltransferase Activity of SETDB1.
Mol Cell.
2016 Jun 16;62(6):958-966. doi: 10.1016/j.molcel.2016.04.022. Epub 2016 May 26. PubMed PMID:
27237050; PubMed Central PMCID:
PMC5346476.
Macromolecular crowding effect is critical for maintaining SIRT1's nuclear localization in cancer cells.
Cell Cycle.
2016 Oct;15(19):2647-2655. doi: 10.1080/15384101.2016.1211214. Epub 2016 Jul 27. PubMed PMID:
27463693; PubMed Central PMCID:
PMC5053580.
Epigenetic regulation of epithelial-mesenchymal transition.
Cell Mol Life Sci.
2016 Dec;73(23):4493-4515. doi: 10.1007/s00018-016-2303-1. Epub 2016 Jul 8. Review. PubMed PMID:
27392607; PubMed Central PMCID:
PMC5459373.
Tumor cell senescence response produces aggressive variants.
Cell Death Discov.
2017;3:17049. doi: 10.1038/cddiscovery.2017.49. eCollection 2017. PubMed PMID:
28845296; PubMed Central PMCID:
PMC5563524.
Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis.
Oncogene.
2022 Jun;41(24):3370-3380. doi: 10.1038/s41388-022-02345-3. Epub 2022 May 11. PubMed PMID:
35546351; PubMed Central PMCID:
PMC9801494.
What would you like to do?